Surbhi Sarna

Surbhi Sarna is a General Partner at Y Combinator, where she invests in and advises early-stage healthcare and medtech startups. Previously, she was the Founder and CEO of nVision Medical, an ovarian cancer detection company that raised $17 million, conducted three clinical trials, and secured two FDA approvals. Following nVision's acquisition by Boston Scientific for $275 million:generating a 15X return:Sarna remained at the acquiring firm for two years directing a 150-person commercial team. At Y Combinator, she has completed over 1,300 office hours across six batches, advising a portfolio with a combined $6 billion valuation. Additionally, she serves on the boards of seven companies, ranging from Series A startups to public entities with market capitalizations reaching $12 billion. Sarna leverages her entrepreneurial background to focus on advancing early-stage medtech and healthcare diagnostic ventures.